Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07121738 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer

Study acronym: HEAL-GYN
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 31, 2026 → Nov 30, 2026
See other at-risk trials from AdventHealth

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Primary and study completion pushed from Aug 31, 2026 to Nov 30, 2026
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 10 of 17 entries
    • Site details revised
    • Publications: details revised at 10 of 11 entries
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2026 to Dec 8, 2025
    • Site details revised
    v3
  3. Start date: Sep 1, 2025 to Jan 1, 2026v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AdventHealth
31 trials monitored
See 2 trials at risk
This study will examine the effects of an 8-week intervention called the Healthy Eating Active Lifestyle (HEAL)-GYN program on participants' 1) self-efficacy 2) lifestyle factors, including physical activity and diet, as well as mental health and overall well-being, and 3) biometrics and biomarkers.
Trial Details
NCT Number NCT07121738
Lead Sponsor AdventHealth
Collaborators: State of Florida Department of Health
Conditions
(from sponsor)		 Gynecologic Cancers
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov